Headline News

 

Novo Nordisk secures exclusive global license from Hengrui Pharma for once-weekly oral GLP-1/GIP dual agonist HRS-1596

Posted on September 29, 2026

Lilly unveils Change the Course Commitment aimed at closing diabetes and obesity treatment gaps in lower-income countries

Posted on September 29, 2026

Lilly’s Foundayo at 17.2 mg outperforms 25 mg oral semaglutide on weight loss and A1C reduction, new indirect treatment comparison finds

Posted on September 29, 2026

Pfizer to showcase new cancer research spanning current standards of care and emerging pipeline breakthroughs at ESMO 2026

Posted on September 29, 2026

Alexion strengthens research leadership in gMG care with new data at 2026 AANEM Annual Meeting and MGFA Scientific Session

Posted on September 29, 2026

Perioperative Imfinzi combined with neoadjuvant enfortumab vedotin secures Priority Review status in the US for muscle-invasive bladder cancer patients

Posted on September 29, 2026

AstraZeneca commits $2 billion to Summit Therapeutics as part of new equity stake and cancer research alliance centered on antibody drug conjugate combinations

Posted on September 29, 2026

Astellas begins Phase III trial of setidegrasib in KRAS G12D mutated advanced lung cancer

Posted on September 29, 2026

EMPAVELI reduces proteinuria and stabilises kidney function in adolescents with C3G or primary IC MPGN

Posted on September 29, 2026

FDA approves Teva’s DEGEVMA biosimilar to Xgeva across all reference product indications

Posted on September 29, 2026

Roche reports positive Phase III interim results for sefaxersen in IgA nephropathy

Posted on September 29, 2026

Abbott data links continuous glucose monitoring with lower mortality and hospitalisation risk in type 2 diabetes

Posted on September 29, 2026

FDA approves AbbVie’s JUVMO for adults with Parkinson’s disease

Posted on September 29, 2026

CARVYKTI delivers five year treatment free remission in half of early line relapsed multiple myeloma patients

Posted on September 29, 2026

TREMFYA improves spinal symptoms and MRI confirmed inflammation in Phase IV axial psoriatic arthritis study

Posted on September 29, 2026